ARTICLE | Company News
Takeda gastrointestinal news
April 16, 2012 7:00 AM UTC
Takeda said the Osaka Regional Tax Bureau (ORTB) concluded a reinvestigation of a 2006 correction notice relating to product supply and licensing transactions of peptic ulcers drug Prevacid lansopraz...